Literature DB >> 24623136

The benefits of nCPAP versus intubation for severe bronchiolitis.

Peter Jones1, Stephane Dauger.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24623136     DOI： 10.1007/s00134-014-3245-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

2.  Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease.

Authors:  Martin C J Kneyber; Heleen Blussé van Oud-Alblas; Margreet van Vliet; Cuno S P M Uiterwaal; Jan L L Kimpen; Adrianus J van Vught
Journal:  Intensive Care Med       Date:  2005-04-01       Impact factor: 17.440

3.  Incidence of and risk factors for airway complications following endotracheal intubation for bronchiolitis.

Authors:  Jeffrey Jorgensen; Julie L Wei; Kevin J Sykes; Stephen A Klem; Robert A Weatherly; Daniel E Bruegger; Adriane D Latz; Pamela J Nicklaus
Journal:  Otolaryngol Head Neck Surg       Date:  2007-09       Impact factor: 3.497

4.  Improved clinical and economic outcomes in severe bronchiolitis with pre-emptive nCPAP ventilatory strategy.

Authors:  Sandrine Essouri; Marie Laurent; Laurent Chevret; Philippe Durand; Emmanuelle Ecochard; Vincent Gajdos; Denis Devictor; Pierre Tissières
Journal:  Intensive Care Med       Date:  2013-10-25       Impact factor: 17.440
  4 in total
  2 in total

1.  Predictors of difficult intubation in ICU: are children and adults alike?

Authors:  Audrey De Jong; Arun K Baranwal; Samir Jaber
Journal:  Intensive Care Med       Date:  2014-08-28       Impact factor: 17.440

2.  Response to Jones et al.: Revisiting the benefits of nCPAP versus intubation for severe bronchiolitis.

Authors:  S Essouri; M Laurent; L Chevret; P Durand; E Ecochard; Vincent Gajdos; D Devictor; P Tissières
Journal:  Intensive Care Med       Date:  2014-03-13       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.